Neurotrophic Role of the Next-Generation Probiotic Strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson’s Disease via Inhibiting Ferroptosis

Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691 · see citing works

Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease

Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695 · see citing works

The Microbiota-Gut-Brain Axis

Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286 · see citing works

ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition

Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293 · see citing works

Epidemiology of Parkinson's disease

de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110 · see citing works

Parkinson's disease

Bloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920 · see citing works

The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis

Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703 · see citing works

Targeting the KEAP1-NRF2 system to prevent kidney disease progression

Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447 · see citing works

FSP1 is a glutathione-independent ferroptosis suppressor

Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341 · see citing works

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479 · see citing works

Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1

Drucker, D. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.001 · Cited by 2,170 · see citing works

Pharmacological Treatment of Parkinson Disease

Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,510 · see citing works

Parkinson disease-associated cognitive impairment

Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C. G., Chaudhuri, К. R., & Weintraub, D. A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,441 · see citing works

Protocol for the MPTP mouse model of Parkinson's disease

Jackson-Lewis, V. R., & Przedborski, S. (2007) · Nature Protocols · doi:10.1038/nprot.2006.342 · Cited by 1,118 · see citing works

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease

Murer, M. G., Yan, Q., & Raisman-Vozari, R. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00014-9 · Cited by 874 · see citing works

Cell Biology of Tight Junction Barrier Regulation and Mucosal DiseasePreprint

Buckley, A., & Turner, J. R. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029314 · Cited by 725 · see citing works

Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC

Do Van, B., Gouel, F., Jonneaux, A., Timmerman, K., Gelé, P., Pétrault, M., Bastide, M., Laloux, C., Moreau, C., Bordet, R., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.011 · Cited by 689 · see citing works

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naive Parkinson's disease patients

Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642 · see citing works

Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease

Mahoney‐Sanchez, L., Bouchaoui, H., Ayton, S., Devos, D., Duce, J. A., & Devedjian, J.-C. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101890 · Cited by 558 · see citing works

Exenatide and the treatment of patients with Parkinson's disease

Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., Djamshidian, A., Ell, P., Soderlund, T., Whitton, P., Wyse, R., Isaacs, T., Lees, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68295 · Cited by 529 · see citing works

A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion.

Li, Y., Maher, P., & Schubert, D. (1997) · Neuron · doi:10.1016/s0896-6273(00)80953-8 · Cited by 509 · see citing works

Transferrin: structure, function and potential therapeutic actions

Gomme, P. T., McCann, K. B., & Bertolini, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03333-1 · Cited by 480 · see citing works

In Alzheimer’s Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial

Gejl, M., Gjedde, A., Egefjord, L., Møller, A., Hansen, S. B., Vang, K., Rodell, A., Brændgaard, H., Gottrup, H., Schacht, A., et al. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00108 · Cited by 480 · see citing works

Transferrin and Transferrin Receptor Function in Brain Barrier Systems

Moos, T., & Morgan, E. H. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006948027674 · Cited by 394 · see citing works

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · see citing works

Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease

Pearce, R. K. B., Owen, A., Daniel, S. E., Jenner, P. G., & MARSDEN, C. D. (1997) · Journal of Neural Transmission · doi:10.1007/bf01291884 · Cited by 350 · see citing works

Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases

Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298 · see citing works

Leaky Gut, Leaky Brain?

Obrenovich, M. E. (2018) · Microorganisms · doi:10.3390/microorganisms6040107 · Cited by 258 · see citing works

Glutathione peroxidase 4-catalyzed reduction of lipid hydroperoxides in membranes: The polar head of membrane phospholipids binds the enzyme and addresses the fatty acid hydroperoxide group toward the redox center

Cozza, G., Rossetto, M., Bosello-Travain, V., Maiorino, M., Roveri, A., Toppo, S., Zaccarin, M., Zennaro, L., & Ursini, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.07.010 · Cited by 182 · see citing works

Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice

Zhong, S., Ge, Q.-H., Qu, R., Li, Q., & Ma, S. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.10.008 · Cited by 161 · see citing works

Astaxanthin alleviates brain aging in rats by attenuating oxidative stress and increasing BDNF levels

Wu, W., Wang, X., Xiang, Q., Meng, X., Ye, P., Du, N., Liu, Z., Sun, Q., Wang, C., & Liu, X. (2013) · Food & Function · doi:10.1039/c3fo60400d · Cited by 146 · see citing works

A New Treatment Strategy for Parkinson's Disease through the Gut–Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway

Kim, D. S., Choi, H.-I., Wang, Y., Luo, Y., Hoffer, B. J., & Greig, N. H. (2017) · Cell Transplantation · doi:10.1177/0963689717721234 · Cited by 136 · see citing works

Iron and reactive oxygen species activity in parkinsonian substantia nigra

del Nogal, A. W., Gałązka-Friedman, J., Bauminger, E. R., Wszołek, Z. K., Schweitzer, K. J., Dickson, D. W., Jaklewicz, A., Elbaum, D., & Friedman, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.007 · Cited by 117 · see citing works

Liraglutide Alleviates Cognitive Deficit in db/db Mice: Involvement in Oxidative Stress, Iron Overload, and Ferroptosis

An, J., Su, J., Sun, G.-Y., Wang, Q., Fan, Y., Jiang, N., Yang, Y., & Shi, Y. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03442-7 · Cited by 107 · see citing works

Nrf2 activator via interference of Nrf2-Keap1 interaction has antioxidant and anti-inflammatory properties in Parkinson's disease animal model

Kim, S., Viswanath, A. N. I., Park, J., Lee, H. E., Park, A. Y., Choi, J., Kim, H. J., Londhe, A. M., Jang, B. K., Lee, J., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107989 · Cited by 106 · see citing works

Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis

Michaličková, D., Hrnčíř, T., Canová, N. K., & Slanař, O. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172973 · Cited by 103 · see citing works

Glucagon-like peptides 1 and 2 in health and disease: A review

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.014 · Cited by 100 · see citing works

Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease

Bergsland, N., Zivadinov, R., Schweser, F., Hagemeier, J., Lichter, D. G., & Guttuso, T. J. (2019) · Movement Disorders · doi:10.1002/mds.27730 · Cited by 75 · see citing works

Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1

Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72 · see citing works

Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease

Fang, X., Zhou, X., Miao, Y., Han, Y., Wei, J., & Chen, T. (2020) · AMB Express · doi:10.1186/s13568-020-01014-6 · Cited by 70 · see citing works

Apoferritin improves motor deficits in MPTP-treated mice by regulating brain iron metabolism and ferroptosis

Song, L., Xiao, Z., Zhang, N., Yu, X., Cui, W., Xie, J., & Xu, H. (2021) · iScience · doi:10.1016/j.isci.2021.102431 · Cited by 62 · see citing works

Changes of Colonic Bacterial Composition in Parkinson’s Disease and Other Neurodegenerative DiseasesPreprint

Gerhardt, S., & Mohajeri, M. H. (2018) · Preprints.org · doi:10.20944/preprints201804.0370.v1 · Cited by 56 · see citing works

Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1

Chen, T., Tian, P., Huang, Z., Zhao, X., Wang, H., Xia, C., Wang, L., & Wei, H. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9155-6 · Cited by 52 · see citing works

Gut microbiota and metabolites of α-synuclein transgenic monkey models with early stage of Parkinson’s disease

Yan, Y., Ren, S., Duan, Y., Lu, C., Niu, Y., Wang, Z., Inglis, B., Ji, W., Zheng, Y., & Si, W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00242-3 · Cited by 51 · see citing works

Reasonably activating Nrf2: A long-term, effective and controllable strategy for neurodegenerative diseases

Li, Q., Xing, S., Chen, Y., Liao, Q., Li, Q., Liu, Y., He, S., Feng, F., Chen, Y., Zhang, J., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111862 · Cited by 43 · see citing works

Deficits in motor and cognitive functions in an adult mouse model of hypoxia-ischemia induced stroke

Feng, L., Han, C.-X., Cao, S.-Y., He-Ming, Z., & Wu, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-77678-8 · Cited by 43 · see citing works

Engineered Bacteria of MG1363-pMG36e-GLP-1 Attenuated Obesity-Induced by High Fat Diet in Mice

Wang, L., Chen, T., Wang, H., Wu, X., Cao, Q. N., Wen, K., Deng, K., & Xin, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.595575 · Cited by 40 · see citing works

Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson’s disease (PD) – A road to discovery?

Jayaramayya, K., Iyer, M., Venkatesan, D., Balasubramanian, V., Narayanasamy, A., Subramaniam, M. D., Cho, S., & Vellingiri, B. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.02.001 · Cited by 34 · see citing works

Antidiabetic effect of an engineered bacterium Lactobacillus plantarum-pMG36e -GLP-1 in monkey model

Luo, J., Zhang, H., Lu, J., Ma, C., & Chen, T. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.09.009 · Cited by 32 · see citing works

Administering Anesthesia to Mice, Rats, and HamstersPreprint

Greenfield, E. A. (2019) · Cold Spring Harbor Protocols · doi:10.1101/pdb.prot100198 · Cited by 19 · see citing works

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

Calkwood, J., Vollmer, T. L., Fox, R. J., Zhang, R., Novas, M., Sheikh, S. I., & Viglietta, V. (2015) · International Journal of MS Care · doi:10.7224/1537-2073.2015-020 · Cited by 7 · see citing works

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases

Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193 · see citing works

FSP1: a key regulator of ferroptosis

Li, W., Liang, L., Liu, S., Yi, H., & Zhou, Y. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.05.013 · Cited by 296 · see citing works

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential

Ding, X.-S., Gao, L., Han, Z., Eleuteri, S., Shi, W., Shen, Y., Song, Z.-Y., Su, M., Yang, Q., Qu, Y., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102077 · Cited by 199 · see citing works

The influence of microbiota on ferroptosis in intestinal diseases

Yao, T. S., & Li, L. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2263210 · Cited by 72 · see citing works

Gut microbiota bridges the iron homeostasis and host health

Xiao, L., Tang, R., Wang, J., Wan, D., Yin, Y., & Xie, L. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2302-5 · Cited by 70 · see citing works

Akkermansia muciniphila Is Beneficial to a Mouse Model of Parkinson’s Disease, via Alleviated Neuroinflammation and Promoted Neurogenesis, with Involvement of SCFAs

Qiao, C.-M., Huang, W., Zhou, Y., Quan, W., Niu, G.-Y., Li, T., Zhang, M.-X., Wu, J., Zhao, L., Zhao, W.-J., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14030238 · Cited by 57 · see citing works

Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies

Zhou, M., Xu, K., Ge, J., Luo, X., Wu, M., Wang, N., & Zeng, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313042 · Cited by 50 · see citing works

Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease

Shen, J., Chen, S., Li, X., Wu, L., Mao, X., Jiang, J., & Zhu, D. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04116-w · Cited by 41 · see citing works

Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

Diz-Chaves, Y., Mastoor, Z., Spuch, C., Lamas, J. A., González-Matías, L. C., & Mallo, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.389626 · Cited by 39 · see citing works

Gut microbiota and Parkinson’s disease

Wang, L., Cui, Y., Han, B., Du, Y., Salewala, K. S., Wang, S., Zhao, W., Zhang, H., Wang, S., Xu, X., et al. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003318 · Cited by 31 · see citing works

Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease

Mao, Z., Gao, Z., Pan, S.-K., Liu, D., Liu, Z., & Wu, P. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02000-8 · Cited by 30 · see citing works

The Role of Cellular Defense Systems of Ferroptosis in Parkinson’s Disease and Alzheimer’s Disease

Chu, J., Li, J., Sun, L., & Wei, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814108 · Cited by 28 · see citing works

The Role of Calcium and Iron Homeostasis in Parkinson’s Disease

Wang, J., Zhao, J., Zhao, K., Wu, S., Chen, X., & Hu, W. (2024) · Brain Sciences · doi:10.3390/brainsci14010088 · Cited by 28 · see citing works

Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut–Brain Axis Therapies

Li, M., Tong, F., Wu, B., & Dong, X. (2024) · Brain Sciences · doi:10.3390/brainsci14121295 · Cited by 29 · see citing works

Roles of ACSL4/GPX4 and FSP1 in oxalate-induced acute kidney injury

Ye, K., Lan, R., Chen, Z., Lai, K., Song, Y., Li, G., Ma, H., Chen, H., & Xu, Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02557-y · Cited by 22 · see citing works

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works

Probiotics as Potential Treatments for Neurodegenerative Diseases: a Review of the Evidence from in vivo to Clinical Trial

Kim, J. H., Choi, Y., Lee, S.-M., & Oh, M. S. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.215 · Cited by 21 · see citing works

Targeting NKAα1 to treat Parkinson's disease through inhibition of mitophagy-dependent ferroptosis

Zhang, X., Li, G., Chen, H., Nie, X.-W., & Bian, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.04.002 · Cited by 20 · see citing works

The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review

Panaitescu, P.-Ș., Răzniceanu, V., Mocrei-Rebrean, Ș.-M., Neculicioiu, V. S., Dragoș, H.-M., Costache, C. A., & Filip, G. A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050244 · Cited by 18 · see citing works

Microbiota-Gut-Brain Axis in Age-Related Neurodegenerative Diseases

Nie, T., Li, Y., Tang, F., Duan, Y., Nepovimová, E., Kuča, K., Wu, Q., & Wei, W. (2024) · Current Neuropharmacology · doi:10.2174/1570159x23666241101093436 · Cited by 19 · see citing works

Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy

Wang, W., Thomas, E. R., Xiao, R., Chen, T., Guo, Q., Liu, K., Yang, Y., & Li, X. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110439 · Cited by 16 · see citing works

Administration of a Next‐Generation Probiotic Escherichia coli Nissle 1917‐GLP‐1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes

Luo, J., Fang, Y., Qi, Z., Cui, F., Hu, H., Li, S., Chen, T., & Zhang, H. (2025) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/cjid/6675676 · Cited by 15 · see citing works

Epigenetic regulation of iron metabolism and ferroptosis in Parkinson’s disease: Identifying novel epigenetic targets

Gao, X., Ding, J.-E., Xie, J., & Xu, H. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01499-6 · Cited by 15 · see citing works

Crosstalk Between Microbiome and Ferroptosis in Diseases: From Mechanism to Therapy

Ding, S., Lei, Y., Zhao, Z., Li, X., Lang, J., Zhang, J., Li, Y., Zhang, C., & Dai, D. (2025) · Comprehensive physiology · doi:10.1002/cph4.70042 · Cited by 14 · see citing works

From pathogenesis to treatment: the emerging role of ferroptosis in Parkinson’s disease

Tu, R., Han, Z., Zhang, H., Jia, X., Sun, T., Liu, H., Li, J., Tang, M., & Wang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1709561 · Cited by 14 · see citing works

The role of microbiota dysbiosis in Parkinson’s disease: Pathophysiology and therapeutic opportunities

Santos, S., Salinas, I., Almeida, N., & Caicedo, A. (2025) · Engineering Microbiology · doi:10.1016/j.engmic.2025.100222 · Cited by 13 · see citing works

Mapping the Research of Ferroptosis in Parkinson’s Disease from 2013 to 2023: A Scientometric Review

Chen, Y., Wu, Z., Li, S., Chen, Q., Wang, L., Qi, X., Tian, C., & Yang, M. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s458026 · Cited by 12 · see citing works

The Role of Probiotics in Modulating the Gut Microbiome in Alzheimer’s Disease: A Review

Dong, Y., Wu, X., Zhang, Y., Hu, A., Zhou, Q., Yue, X., Liu, Z., & Li, M. (2025) · Foods · doi:10.3390/foods14091531 · Cited by 14 · see citing works

Gut microbiota and Parkinson’s disease: exploring pathogenesis and potential therapeutic strategies from a gut-brain axis perspective

Jin, X., Wei, J., Min, X., Fan, Y., Yuan, Z., Du, Z., Su, Z., Xun, T., Du, Q., Liang, T., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114185 · Cited by 10 · see citing works

Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives

Guo, J., Zhou, B., Niu, Y., Liu, L., & Yang, L. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01279-1 · Cited by 10 · see citing works

LPL-RH suppresses bone loss in ovariectomised rat models

Chen, W., Wang, X.-L., Wang, Y., Liu, D., Yue, M., Wei, J., Li, J., Chen, T., & Tu, H. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03683-w · Cited by 10 · see citing works

Iron toxicity, ferroptosis and microbiota in Parkinson’s disease: Implications for novel targets

Carvalho, F. V., Landis, H. E., Getachew, B., da Silva, V. D. A., ribeiro, P. R. R., Aschner, M., & Tizabi, Y. (2024) · Advances in neurotoxicology · doi:10.1016/bs.ant.2024.02.001 · Cited by 9 · see citing works

Advice to People with Parkinson’s in My Clinic: Probiotics and Prebiotics

Hor, J. W., Toh, T. S., Lim, S., & Tan, A. H. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240172 · Cited by 9 · see citing works

Origins of nervous tissue susceptibility to ferroptosis

Snyder, J., & Wu, Z. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100091 · Cited by 9 · see citing works

Lactiplantibacillus plantarum Ameliorated Morphological Damage and Barrier Dysfunction and Reduced Apoptosis and Ferroptosis in the Jejunum of Oxidatively Stressed Piglets

Liu, Y., Yuan, J., Wu, X., Wang, Z., Liu, H., Zhang, K., Zhao, J., & Wang, Y. (2024) · Animals · doi:10.3390/ani14223335 · Cited by 8 · see citing works

Potential applications of engineered bacteria in disease diagnosis and treatment

Luo, Z., Qi, Z., Luo, J., & Chen, T. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.57 · Cited by 9 · see citing works

Deciphering the microbial map and its implications in the therapeutics of neurodegenerative disorder

Vashishth, S., Ambasta, R. K., & Kumar, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102466 · Cited by 7 · see citing works

The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson’s disease

Yue, M., Chen, T., Chen, W., Wei, J., Liao, B., Zhang, J., Li, F., Hong, D., & Fang, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00702 · Cited by 8 · see citing works

Ferroptosis in Parkinson’s disease: a review of molecular mechanisms and emerging therapeutic strategies

Wang, L., Zhang, Y., & Guo, L. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1780573 · Cited by 6 · see citing works

Dietary and nutritional interventions for human diseases: their modulatory effects on ferroptosis

Huang, S., Sun, J. S., Shen, C., & He, G. (2025) · Food & Function · doi:10.1039/d4fo05606j · Cited by 6 · see citing works

Harnessing the gut microbiome to modulate ferroptosis: a metabolic strategy for the treatment of digestive tract cancers

Wen, J., Liang, H., Zhao, M., Xuan, B., Meng, X., Liu, Y., Wang, L., He, L., Zhou, T., Tao, Y., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703964 · Cited by 4 · see citing works

Stigmasterol exerts antioxidant effects through activation of the Keap1/Nrf2 signaling pathway in Parkinson’s disease model

Tong, Y., Qu, Q., Wan, Z., Luo, Q., Xu, R., & Qu, S. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07502-2 · Cited by 4 · see citing works

Dietary supplements for Parkinson's disease: State of the science

Prasad, A., Shuler, M. G. H., Flanagan, R., Dayal, V., & Lithander, F. E. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261446386 · Cited by 4 · see citing works

Research trends of ferroptosis and pyroptosis in Parkinson’s disease: a bibliometric analysis

Wu, T.-H., Zhong, K., Tang, B., & Xie, S. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1400668 · Cited by 4 · see citing works

Probiotics combination effectively improves constipation in pregnancy by modifying the gut microbiota composition

He, X., Chen, W., Wang, Y., Chen, H., Xu, X., Zhao, X., Zhou, D., Yue, M., Wei, J., & Chen, T. (2024) · Beneficial Microbes · doi:10.1163/18762891-bja00020 · Cited by 4 · see citing works

Recombinant Amuc_1100 Lactococcus lactis regulates metabolism and intestinal health of largemouth bass fed high starch diet

Yang, G., Yin, M., Guo, S., Yang, B., Gu, J., Zhang, Y., Zhang, Y., 张新党, Chang, X., Feng, S., et al. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743232 · Cited by 3 · see citing works

FSP1, a key ferroptosis suppressor with therapeutic potential

Bai, X., Zhu, J., Xiong, B., Chen, Y., Xu, C., Zhao, Q., Wu, Y., Tang, Z., Shi, R., Liu, Z., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118151 · Cited by 3 · see citing works

The suppression of FSP1 expression via NRF2 promotes ferroptosis induced by reactive oxygen species in vascular smooth muscle cells

Xie, Z., Guo, J., Deng, Y., Yu, P., Zhi, C., He, Y., Tan, X., Lin, X., Lin, X., Ma, W., et al. (2024) · Process Biochemistry · doi:10.1016/j.procbio.2024.05.007 · Cited by 3 · see citing works

Study of molecular patterns associated with ferroptosis in Parkinson’s disease and its immune signature

Chen, L., Xin, G., He, Y., Tian, Q., Kong, X., Fu, Y., Wang, J., Zhang, H., & Wang, L. (2023) · PLoS ONE · doi:10.1371/journal.pone.0295699 · Cited by 3 · see citing works

Targeting autophagy and programmed cell death in neurological diseases via probiotic intervention

Chen, L., Sabihi, S.-S., & Zhang, C. (2025) · Gut Pathogens · doi:10.1186/s13099-025-00787-0 · Cited by 2 · see citing works

Gut bacteria composition in animal models of Parkinson’s disease: a systematic review and meta-analysis

Elford, J. D., Heesbeen, E. J., van der Plaats, N. A., Garssen, J., Kraneveld, A. D., Groenink, L., & Perez‐Pardo, P. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01236-0 · Cited by 2 · see citing works

Engineered Clostridium butyricum-pMTL007-GLP-1 Delays Neurodegeneration in Prnp-SNCA*A53T Transgenic Mice Model by Suppressing Astrocyte Senescence

Liao, B., Ding, L., Chen, W., Yue, M., Wang, Y., Hong, D., Chen, T., & Fang, X. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10638-8 · Cited by 2 · see citing works

Genetically Engineered Probiotics and Their Potential in Therapeutic Applications

Bulut, S. D., & Çelebioğlu, H. U. (2024) · Springer eBooks · doi:10.1007/978-981-96-0297-1_5 · Cited by 1 · see citing works

Protective Effects of Deinoxanthin on Brain Oxidative Damage and Gut Microbiota in the D-Galactose-Induced Aging Mice

Su, H., Li, Y., Wan, J., Lin, J., Wang, J., Fan, R., Liu, D., Wei, J., Xin, H., Hua, Y., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05215-7 · Cited by 1 · see citing works

Akkermansia muciniphila: A double-edged sword in life-stage-specific nutritional modulation of Parkinson’s disease via the gut-brain axis

Chen, N., Pang, D., & Shang, H. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128436 · Cited by 3 · see citing works

Bridging the gap: Unveiling the gut's influence on Parkinson's disease through probiotic interventions

Nápoles-Medina, A. Y., Aguilar-Uscanga, B. R., Nápoles-Medina, B. G., Brand-Rubalcava, P. A., Tejeda-Martínez, A. R., & Flores-Soto, M. E. (2025) · Neurology Perspectives · doi:10.1016/j.neurop.2025.100206

Elucidating the Neuroprotective Mechanism of Geissoschizine Methyl Ether against Parkinson’s Disease: Inhibition of Ferroptosis Pathway via Network Pharmacology and In Vitro Validation

Wan, H., Yusun, A., Chen, H., Wang, Q., Li, Y., Zhang, W., Ding, X., & Zhang, C. (2025) · ACS Omega · doi:10.1021/acsomega.5c06460

Construction of an mKate-based fluorescent protein reporting system in Limosilactobacillus reuteri

Wang, Y., Wang, X., Wu, D., Hong, W., Kang, Y., Li, R., Yang, G., Yan, H., Chen, Z., & Cui, G. (2025) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2025.107347

Interactions between the gut microbiome and ferroptosis in degenerative diseases: Novel mechanisms and potential therapeutic strategies

Chen, Y., Wei, X., Yi, X., & Jiang, D. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.01.020

Prebiotics, Probiotics, and Postbiotics in Therapy

Sobti, R. C., Negi, R. K., & Rana, A. (2026) · Springer eBooks · doi:10.1007/978-981-95-9031-5_6

Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism

Su, B., Meng, F., Yao, L., Zhang, Y., Wang, T., Zhang, Y., Liu, J., & Lin, L. (2026) · Antioxidants · doi:10.3390/antiox15070882

Research Progress on the Role of Ferroptosis in the Pathogenesis of Parkinson’s Disease

折, 洁. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1693164

Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1

Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72 · see citing works

The engineered probiotic strain Lactococcus lactis MG1363-pMG36e-GLP-1 regulates microglial polarization and gut dysbiosis in a transgenic mouse model of Parkinson’s disease

Yue, M., Chen, T., Chen, W., Wei, J., Liao, B., Zhang, J., Li, F., Hong, D., & Fang, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00702 · Cited by 8 · see citing works

Lactobacillus acidophilus exerts neuroprotective effects in MPTP mice: potential links to the gut microbiota and GLP-1

Yang, L., Guo, T., Wei, Y., Zhang, Z., Sun, Y., Yan, N., Ding, S., Jiang, L., & Liu, H. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115229 · Cited by 1 · see citing works

Lactobacillus reuteri DSM 17938 and Its Supernatant Ameliorate Parkinson’s Disease in Association with Modulation of Gut Microbiota and Its Tryptophan Metabolism

Su, B., Meng, F., Yao, L., Zhang, Y., Wang, T., Zhang, Y., Liu, J., & Lin, L. (2026) · Antioxidants · doi:10.3390/antiox15070882

Lactobacillus reuteri-derived γ-amino butyric acid alleviates MPTP-induced Parkinson’s disease through inhibiting ferroptosis via the AKT-GSK3β-GPX4 axis

Dong, X., Yang, T., & Jin, Z. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01022-y · Cited by 18 · see citing works